POCP Blog

New POCP Report Examines How States are Addressing Opioid Prescribing, A Root Cause of the Epidemic

By Tony Schueth A first-of-its kind report that details how states are fighting the opioid crisis at the prescription level has been developed by Point of Care Partners (POCP). Unlike …

Combining Health Insurers and Pharmacy Benefit Managers: Bringing Down the Information Silos

By Michael Solomon, PhD, MBA Big moves by market-leading commercial payers signal sweeping transformative change is underway for health insurers and pharmacy benefit managers (PBMs). This change has the potential …

Why the Focus on Medication Noncompliance?

By Tony Schueth Addressing medication noncompliance is one of the trends we will be seeing in 2018. To be sure, medication noncompliance is a long-standing issue. We have known for …

Enhancing Today’s Health IT to Stem the Tide of Opioid Abuse

By Michael Burger, Senior Consultant I read with interest Joel White’s Op-Ed piece entitled Leverage the Power of Health IT to Stem the Tide of Opioid Abuse. One statement stood …

Five Ways the Opioid Epidemic Impacts Electronic Health Records

By Connie Sinclair, Director, Regulatory Resource Center Lawmakers are reacting to America’s opioid epidemic by creating new mandates that will affect electronic health records (EHRs). Compliance will create many challenges …

Good News for Vendors: ONC to Significantly Ratchet Back EHR Certification and Enforcement

By Michael Burger and Chuck Frederick, Senior Consultants Vendors of electronic health records (EHRs) should be doing a happy dance over the recent announcement from the Office of the National …

Missouri Creates a Unique PDMP

By Connie Sinclair, Director, Regulatory Resource Center Until recently, Missouri was the only state without a Prescription Drug Monitoring Program (PDMP).  Growing evidence suggests that use of these state-run databases …

EHRs Are Not a Magic Bullet

  By Michael Burger, Practice Lead, EHRs and EDI Electronic health records (EHRs) are taking a lot of heat these days. Lloyd Minor, M.D., the dean of Stanford University’s School …

How Stakeholders are Affected by FDA’s New Naming Convention for Biologics and Biosimilars

By Pooja Babbrah, Senior Consultant Stakeholders across the industry are debating potential costs and burden associated with implementing the new, nonproprietary naming convention for biologics and biosimilars. Requirements for the …

EHRs Offer Ready-Made Tools for Population Health Management

By Michael Burger, Senior Consultant Providers need tools for population health management (PHM) for reimbursement as well as reporting on metrics for related activities and quality improvement. While most physicians …